BackNOV Overview
NOV Inc

NOV Target Price

Analysts' average 12-month price target for NOV is $22.

Get informed when a big investor buys or sells

+ Follow

Share Price

$20.99

Average Target Price

$22.175.6% upside

6 analysts in the last 4 months

High: $26 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-15Morgan Stanley$210% upsideOpen
2026-07-08Susquehanna$224.8% upsideOpen
2026-06-04Capital One Financial$2623.9% upsideOpen
2026-06-03Goldman Sachs$199.5% downsideOpen
2026-05-07BarclaysDavid Anderson$210% upsideOpen
2026-04-29Susquehanna$2414.3% upsideOpen
2026-04-15Morgan Stanley$204.7% downsideOpen
2026-02-09Piper SandlerDerek Podhaizer$1814.2% downsideOpen
2026-02-06Evercore ISIJason Bandel$199.5% downsideOpen
2026-02-06Stifel Nicolaus$210% upsideOpen
2026-02-06Susquehanna$210% upsideOpen
2026-01-15RBC CapitalKeith Mackey$210% upsideOpen
2026-01-14Goldman Sachs$1719% downsideOpen
2026-01-07SusquehannaCharles Minervino$204.7% downsideOpen
2025-12-18Piper SandlerDerek Podhaizer$1719% downsideOpen
2025-12-17Barclays$1528.5% downsideOpen
2025-12-15Morgan StanleyJoe Laetsch$1623.8% downsideOpen
2025-11-11BarclaysDavid Anderson$1338.1% downsideOpen
2025-11-05Goldman SachsAti Modak$1433.3% downsideOpen
2025-10-30Barclays$1433.3% downsideOpen
2025-10-29Stifel Nicolaus$199.5% downsideOpen
2025-10-29RBC Capital$199.5% downsideOpen
2025-10-28Raymond JamesJames Rollyson$1719% downsideOpen
2025-07-30Susquehanna$1719% downsideOpen
2025-04-15Stifel NicolausStephen Gengaro$239.6% upsideOpen
2025-03-24RBC CapitalKeith Mackey$224.8% upsideOpen
2024-12-18BarclaysDavid Anderson$1242.8% downsideOpen
2024-10-11Stifel NicolausStephen Gengaro$2519.1% upsideOpen
2024-10-10BMO CapitalPhillip Jungwirth$204.7% downsideOpen
2024-09-16Morgan StanleyDaniel Kutz$239.6% upsideOpen
2024-07-30BarclaysDavid Anderson$204.7% downsideOpen
2023-02-08Susquehanna$2938.2% upsideOpen
2022-07-29Morgan Stanley$199.5% downsideOpen
2022-07-13Morgan Stanley$1814.2% downsideOpen
2022-07-13Goldman Sachs$1623.8% downsideOpen
2022-06-08Barclays$224.8% upsideOpen
2022-05-02Barclays$204.7% downsideOpen
2022-02-04Evercore ISIJames West$224.8% upsideOpen
2021-12-09Cowen & Co.Marc Bianchi$199.5% downsideOpen
2021-10-11Morgan StanleyConnor Lynagh$1719% downsideOpen
2021-07-19BMO CapitalPhillip Jungwirth$1528.5% downsideOpen
2021-05-04Coker PalmerVaibhav Vaishnav$1242.8% downsideOpen

NOV (NOV) FAQ

The latest target price for NOV is $22. Investors often review this figure alongside NOV's historical trend and sector peers before judging valuation or financial health.

NOV trades near $20.99 while the consensus target sits at $22 (5.6% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting NOV's target price ($22), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack NOV's target price against similar Industrials names. You can also browse sector and industry screens on Stockcircle for a broader set of Industrials companies and their key multiples and fundamentals.